AQR Arbitrage’s Alder Biopharmaceuticals ALDR Stock Holding History

AQR Arbitrage’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-422,832	Closed	-$7.97M	–	526
2019 Q3	$7.97M	Buy	+422,832	New	+$4.84M	0.12%	155

AQR Arbitrage's ALDR Position: Q4 2019 in Review

AQR Arbitrage sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 422,832 shares — an estimated $7.97M sold.

AQR Arbitrage first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $7.97M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

AQR Arbitrage reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
AQR Arbitrage sold 422,832 Alder Biopharmaceuticals shares in Q4 2019, an estimated $7.97M.
AQR Arbitrage first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
AQR Arbitrage's Alder Biopharmaceuticals position peaked at $7.97M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on AQR Arbitrage's 13F filing for Q4 2019, filed 14 Feb 2020.